J3090 Injection tedizolid phosphate
Also known as: tedizolid, Sivextro, oxazolidinone antibiotic
Tedizolid phosphate injection is a long-acting oxazolidinone antibiotic used for treatment of acute bacterial skin and soft tissue infections including Methicillin-resistant Staphylococcus aureus.
In Plain Language
strong antibiotic injection; infection-fighting medication
Clinical Context
Indicated for acute bacterial skin and skin structure infections caused by susceptible organisms including methicillin-resistant Staphylococcus aureus. Administered intravenously or intramuscularly with broader spectrum coverage than linezolid.
RVU Information
CPT J3090 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J3090?
CPT J3090 (Injection tedizolid phosphate) is a J Codes (Drugs) code. Tedizolid phosphate injection is a long-acting oxazolidinone antibiotic used for treatment of acute bacterial skin and soft tissue infections including Methicillin-resistant Staphylococcus aureus.
How is J3090 administered?
CPT J3090 is administered by a healthcare provider, typically via injection or infusion. Indicated for acute bacterial skin and skin structure infections caused by susceptible organisms including methicillin-resistant Staphylococcus aureus. Administered intravenously or intramuscularly with broader spectrum coverage than linezolid. It is used by Infectious Disease, Dermatology, Internal Medicine.
When is CPT J3090 used?
Indicated for acute bacterial skin and skin structure infections caused by susceptible organisms including methicillin-resistant Staphylococcus aureus. Administered intravenously or intramuscularly with broader spectrum coverage than linezolid.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.